COMPLEXT PATIENT DERIVED ORGANOIDS(CPDOS) MODELING FOR ANTI-CANCER DRUG SCREENING

被引：0
|
作者：
Li, Ling
Knutsdottir, Hildur
Hui, Ken
Weiss, Matthew J.
He, Jin
Philosophe, Benjamin
Cameron, Andrew
Wolfgang, Christopher L.
Pawlik, Timothy M.
Ghiaur, Gabriel
Ewald, Andrew
Mezey, Esteban
Bader, Joel
Selaru, Florin
机构：
来源：
GASTROENTEROLOGY | 2019年 / 156卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
490e
引用
收藏
页码：S1508 / S1508
页数：1
相关论文
共 50 条
  • [31] Zebrafish Patient-Derived Avatars from Digestive Cancers for Anti-cancer Therapy Screening
    Costa, Bruna
    Estrada, Marta F.
    Barroso, Mariana Tavares
    Fior, Rita
    CURRENT PROTOCOLS, 2022, 2 (04):
  • [32] Patient-Derived Organoids as Therapy Screening Platforms in Cancer Patients
    Khorsandi, Danial
    Yang, Jia-Wei
    Foster, Samuel
    Khosravi, Safoora
    Hosseinzadeh Kouchehbaghi, Negar
    Zarei, Fahimeh
    Lee, Yun Bin
    Runa, Farhana
    Gangrade, Ankit
    Voskanian, Leon
    Adnan, Darbaz
    Zhu, Yangzhi
    Wang, Zhaohui
    Jucaud, Vadim
    Dokmeci, Mehmet Remzi
    Shen, Xiling
    Bishehsari, Faraz
    Kelber, Jonathan A.
    Khademhosseini, Ali
    de Barros, Natan Roberto
    ADVANCED HEALTHCARE MATERIALS, 2024, 13 (21)
  • [33] Establishment of Patient-Derived Organoids and Drug Screening for Biliary Tract Carcinoma
    Saito, Yoshimasa
    Muramatsu, Toshihide
    Kanai, Yae
    Ojima, Hidenori
    Sukeda, Aoi
    Hiraoka, Nobuyoshi
    Arai, Eri
    Sugiyama, Yuko
    Matsuzaki, Juntaro
    Uchida, Ryoei
    Yoshikawa, Nao
    Furukawa, Ryo
    Saito, Hidetsugu
    CELL REPORTS, 2019, 27 (04): : 1265 - +
  • [34] DRUG SCREENING OF AVAILABLE ANTI-CANCER DRUGS ON PATIENT-DERIVED GBM CULTURES IDENTIFIES CANDIDATE TREATMENTS FOR A SUBPOPULATION OF GBM PATIENTS
    Ntafoulis, I.
    Kers, T.
    van der Kaaij, M.
    Balvers, R.
    Hayes, J.
    van Rij, J.
    Tching, R.
    Lindner, A.
    Prehn, J.
    Kremer, A.
    Dirven, C.
    Leenstra, S.
    Lamfers, M.
    NEURO-ONCOLOGY, 2019, 21 : 48 - 48
  • [35] Zebrafish-based Screening for Anti-cancer Drug Discovery
    Shimada, Yasuhito
    Yamada, Eiji
    White, Richard
    Zang, Liqing
    Snaar-Jagalska, Ewa
    Spaink, Herman
    Nishimura, Yuhei
    Tanaka, Toshio
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2017, 133 (03) : S79 - S79
  • [36] Microprinted Tumor Spheroids Enable Anti-Cancer Drug Screening
    Thakuri, Pradip S.
    Ham, Stephanie L.
    Tavana, Hossein
    2016 38TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY (EMBC), 2016, : 4177 - 4180
  • [37] Drug screening of non-small cell lung cancer patient-derived organoids in a microwell platform
    Luan, Qiyue
    Pulido, Ines
    Zhou, Jian
    Shimamura, Takeshi
    Papautsky, Ian
    CANCER RESEARCH, 2023, 83 (07)
  • [38] DRUG SCREENING OF PATIENT-DERIVED ORGANOIDS FROM OVARIAN CANCER CULTURE TO PERSONALIZED THERAPY, AN EXPLORATORY RESEARCH
    Wang, H.
    He, M.
    Zhong, L.
    Zou, D.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A105 - A106
  • [39] A novel integrated system using patient-derived glioma cerebral organoids and xenografts for disease modeling and drug screening
    Zhang, Liyang
    Liu, Fangkun
    Weygant, Nathaniel
    Zhang, Junxia
    Hu, Ping
    Qin, Zailong
    Yang, Jingxuan
    Cheng, Quan
    Fan, Fan
    Zeng, Yu
    Tang, Yongjian
    Li, Yusheng
    Tang, Anliu
    He, Fengqiong
    Peng, Jun
    Liao, Weihua
    Hu, Zhongliang
    Li, Min
    Liu, Zhixiong
    CANCER LETTERS, 2021, 500 : 87 - 97
  • [40] Feasibility of Gastric Tumor Xenograft (GTX)-derived Cell Lines for Individualized Anti-cancer Drug Screening
    Oh, Sung Eun
    Oh, Mi Yun
    Kim, Su Mi
    Kim, Sun Young
    An, Ji Yeong
    Lee, Jun Ho
    Sohn, Tae Sung
    Bae, Jae Moon
    Choi, Min-Gew
    ANTICANCER RESEARCH, 2022, 42 (06) : 2883 - 2891
12345